Matt Kaeberlein | Let’s Talk Longevity – Open Q&A | LIC 2025

At the Longevity Investors Conference 2025 in Gstaad, longevity scientist and researcher Matt Kaeberlein joined the Let’s Talk Longevity open Q&A to bring scientific clarity to one of the field’s most debated topics — biological aging clocks. Drawing on two decades of aging-biology research and translational work, Kaeberlein explains why most direct-to-consumer “biological age” tests don’t truly measure aging, and why rigorous validation, precision, and transparency are essential before integrating such tools into clinical practice. He also explores broader themes that define the longevity movement today — from the rise of health-span optimization and lifestyle science to the need for evidence-based decision-making and honest communication between researchers, clinicians, and consumers. 🔹 Key insights: • Why biological aging clocks don’t actually measure biological age • The difference between correlation, precision, and accuracy • Better biomarkers for real-world health prediction • How motivation and transparency can coexist in longevity science • The future of validated diagnostics and longitudinal tracking 🎬 Recorded live at the Longevity Investors Conference 2025 in Gstaad, Switzerland. 📍 Learn more: www.longevityinvestors.ch 📺 Subscribe for more talks and highlights from global leaders in longevity science and investment. #LIC2025 #LongevityInvestors